PATENT CLAIM ANALYSIS

Application Number: 15761012
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigens, for use in the treatment or prevention of  C. burnetii  infection. Also provided are nucleic acids encoding such antigens, and antibodies raised against such antigens.

Claim (Index 48):
An in vitro method for confirming the presence or absence of  C. burnetii  in a patient sample, wherein the presence of a  C. burnetii  is confirmed by detecting the binding of an antibody according to  claim 45  to a  C. burnetii  antigen present in said sample, and wherein failure to detect the binding of an antibody according to  claim 45  to a  C. burnetii  antigen in said sample confirms the absence of  C. burnetii.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 90.0
- Lexical Diversity: 1.17241
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12557741', '11837264', '12614896', '14396881', '12988595']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7084380602490082
- 35 USC 102 Novelty (BERT): 0.5260720092680631
- Combined Prediction Score: 0.6902014551509137
- Mean Citation Score: 259.467096
- Max Citation Score: 263.20352
- Similarity Product: 146.11330088974

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test